NR6A1 and hepatocellular carcinoma: According to the IPS immunotherapy score from TCIA database, high NR6A1, OSBP2 and UNC119B expression were all negatively related to four types of IPS scores, suggesting that the three targets played an inhibitory role in HCC immunotherapy (Fig. 4A–C).